# Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis

Study · id `cardio:ct-nct02686398` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02686398](<https://clinicaltrials.gov/study/NCT02686398>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02686398

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.

## Technical summary

Registry record NCT02686398. Randomized; no masking; primary purpose prevention. Start 2013-10 (registry gives no type); primary completion 2014-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 174 participants (enrolled count; ClinicalTrials.gov record NCT02686398, source copy `cardio:ctgov-nct02686398-2016-02-19`, retrieved 2026-10-26)
- Start date: 2013-10 (registry gives no type) (ClinicalTrials.gov record NCT02686398, source copy `cardio:ctgov-nct02686398-2016-02-19`, retrieved 2026-10-26)
- Primary completion: 2014-11 (actual) (ClinicalTrials.gov record NCT02686398, source copy `cardio:ctgov-nct02686398-2016-02-19`, retrieved 2026-10-26)
- Completion: 2014-11 (actual) (ClinicalTrials.gov record NCT02686398, source copy `cardio:ctgov-nct02686398-2016-02-19`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02686398-2016-02-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis
- Condition: Influenza
- Condition: End Stage Renal Failure
- Condition: Chronic Kidney Disease
- Intervention (Biological): Fluad
- Intervention (Biological): Agrippal
- Lead sponsor: Korea University Guro Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Korea University Guro Hospital (`cardio:org-korea-university-guro-hospital`)

## Provenance

Content hash: 338dd0791cc0b6089b6401828594cb174ba4c4fd2fd770265ec5a891c6ca5432
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
